A detailed history of Walleye Capital LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 30,883 shares of CVRX stock, worth $370,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,883
Previous 14,328 115.54%
Holding current value
$370,287
Previous $450,000 24.89%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.99 - $30.49 $297,824 - $504,761
16,555 Added 115.54%
30,883 $562,000
Q4 2023

Feb 14, 2024

SELL
$11.67 - $33.01 $291,738 - $825,216
-24,999 Reduced 63.57%
14,328 $450,000
Q3 2023

Nov 14, 2023

BUY
$13.56 - $18.47 $533,274 - $726,369
39,327 New
39,327 $596,000
Q2 2022

Aug 08, 2022

SELL
$4.7 - $7.22 $220,768 - $339,137
-46,972 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$5.62 - $12.37 $263,982 - $581,043
46,972 New
46,972 $281,000

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $247M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.